LOI Deadline
Sponsor Deadline
Posted: 5/17/2024

Congressionally Directed Medical Research Programs -- Vision Research Program -- Translational Research Award

The FY24 VRP TRA is intended to support translational research that moves promising discoveries into clinical applications that will advance the prevention, diagnosis, mitigation, and/or treatment of eye injury or visual dysfunction associated with military exposure.

Successful applications to the FY24 VRP TRA should establish a clear path to transforming a promising discovery into new drugs, devices, or clinical practice guidelines that are ready for definitive testing in clinical trials. For new drug or device development, the investigative team should include at least one collaborator with expertise in the regulatory approval process.


• Required Pre-Application Submission Deadline: July 11, 2024

• Application Submission Deadline:  November 8, 2024

Areas of Interest

To meet the intent of the funding opportunity, applications to the FY24 VRP Translational Research Award (TRA) must address research in one or more of the following Focus Areas:

• Understand and treat eye injury or visual dysfunction as related to military exposure
• Diagnose, stabilize, and treat eye injuries in austere environments and prolonged care settings
• Restore visual function after military exposure-related vision loss or severe visual impairment

Eligibility Requirements

Independent investigator at all academic levels (or equivalent) may be named by the organization as the Principal Investigator (PI) on the application. An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by or affiliated with an eligible organization.

Amount Description

The anticipated direct costs budgeted for the entire period of performance for an FY24 VRP TRA should not exceed $1.0M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.